Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13
Morgan Stanley analyst Kallum Titchmarsh maintains $Embecta(EMBC.US)$ with a sell rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 34.8%
BTIG Maintains Embecta(EMBC.US) With Hold Rating
BTIG analyst Marie Thibault maintains $Embecta(EMBC.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 34.3% and a total average return of -1.9% over the past year.
BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC)
Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Raises Target Price to $13
Morgan Stanley analyst Kallum Titchmarsh maintains $Embecta(EMBC.US)$ with a sell rating, and adjusts the target price from $12 to $13.According to TipRanks data, the analyst has a success rate of 31.
Recommendation to Sell: Anticipated Costs and Competition Challenge Embecta's New Pump Program
Embecta Receives 510(K) Clearance From FDA For Its Proprietary Disposable Insulin Delivery System